Ownership and insider activity for Quanterix Corporation (QTRX): insider transactions, US Senate and House trading disclosures and shares outstanding. Track how corporate insiders and politicians are trading the stock.
Quanterix Corporation, based in Billerica, Massachusetts, is a life sciences enterprise dedicated to pioneering and commercializing advanced digital immunoassay platforms. These sophisticated systems are designed to enhance precision health in both scientific research and diagnostic applications, reaching markets across North America, Europe, the Middle East, Africa, and the Asia Pacific regions.
Price
| Price | $2.91 |
| Market Cap | $137M |
| Exchange | NASDAQ |
| Country | US |
Recent Insider Transactions
| Date | Insider | Type | Shares | Value |
|---|---|---|---|---|
| 2026-09-15 | Miller Michael Francis | M-Exempt | 834 | |
| 2026-09-15 | Miller Michael Francis | F-InKind | 249 | $677 |
| 2026-09-15 | Miller Michael Francis | M-Exempt | 372 | |
| 2026-09-15 | Miller Michael Francis | F-InKind | 111 | $302 |
| 2026-09-15 | Miller Michael Francis | M-Exempt | 135 | |
| 2026-09-15 | Miller Michael Francis | F-InKind | 41 | $112 |
| 2026-09-15 | Miller Michael Francis | M-Exempt | 136 | |
| 2026-09-15 | Miller Michael Francis | F-InKind | 41 | $112 |
| 2026-09-15 | Miller Michael Francis | M-Exempt | 81 | |
| 2026-09-15 | Miller Michael Francis | F-InKind | 25 | $68 |
Balance Sheet (10y)
| Year | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $29.7M | $79.7M | $45.4M | $109.2M | $181.6M | $396.5M | $338.7M | $174.4M | $56.7M | $29.8M |
| Short-term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | $146.9M | $232.4M | $88.4M |
| Receivables | $3.9M | $5.6M | $6.8M | $10.9M | $17.2M | $23.8M | $19.0M | $25.4M | $32.1M | $30.0M |
| Inventory | $1.5M | $3.6M | $6.0M | $10.5M | $14.9M | $22.2M | $17.0M | $26.1M | $32.8M | $54.8M |
| Total Current Assets | $35.2M | $89.3M | $60.5M | $132.7M | $219.6M | $449.0M | $381.5M | $382.1M | $363.6M | $212.3M |
| Property, Plant & Equipment | $1.2M | $1.9M | $2.9M | $12.0M | $25.9M | $29.5M | $41.0M | $36.2M | $33.5M | $40.3M |
| Goodwill | 0 | 0 | $1.3M | $9.4M | $10.5M | $9.6M | 0 | 0 | 0 | $26.4M |
| Intangible Assets | 0 | 0 | $2.3M | $14.3M | $13.7M | $10.5M | $7.5M | $6.0M | $4.0M | $131.8M |
| Total Assets | $37.1M | $91.8M | $67.6M | $170.0M | $271.0M | $506.5M | $433.6M | $428.6M | $406.5M | $418.8M |
| Accounts Payable | $2.5M | $3.6M | $5.1M | $5.8M | $6.8M | $9.2M | $3.8M | $5.0M | $7.0M | $13.6M |
| Short-term Debt | $899000 | $5.0M | 0 | $75000 | $7.7M | 0 | 0 | 0 | 0 | 0 |
| Total Current Liabilities | $11.0M | $19.7M | $17.7M | $19.8M | $39.8M | $37.0M | $31.3M | $39.0M | $42.0M | $74.8M |
| Long-term Debt | $9.3M | $4.3M | $7.6M | $7.6M | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Liabilities | $23.6M | $25.9M | $26.1M | $41.3M | $64.9M | $65.6M | $75.7M | $78.6M | $76.5M | $123.0M |
| Retained Earnings | -$115.1M | -$144.4M | -$175.9M | -$216.2M | -$247.8M | -$305.5M | -$403.2M | -$431.6M | -$470.1M | -$577.2M |
| Total Equity | $13.5M | $65.9M | $41.6M | $128.7M | $206.1M | $441.0M | $357.9M | $350.0M | $330.0M | $295.7M |
| Total Debt | $10.2M | $9.4M | $7.6M | $7.7M | $30.8M | $21.9M | $44.1M | $41.5M | $37.4M | $37.2M |
| Net Debt | -$19.4M | -$70.3M | -$37.8M | -$101.5M | -$150.8M | -$374.6M | -$294.6M | -$279.9M | -$251.8M | -$81.0M |
| Working Capital | $24.3M | $69.5M | $42.9M | $112.8M | $179.8M | $412.0M | $350.2M | $343.1M | $321.6M | $137.5M |
Financial Health
| Debt / Equity | 0.14 |
| Current Ratio | 3.40 |
| Piotroski F-Score | 2 |
| Altman Z-Score | -0.75 |
Profitability
| Return on Equity | -43.59% |
| Return on Invested Capital | -46.86% |
| Return on Assets | -38.52% |
| Gross Margin | 42.60% |
| Operating Margin | -86.19% |
| Net Margin | -80.29% |
Related companies: CVRX · IMRX · INGN · MASS · NNOX · OM · SENS
Explore sector: Healthcare · Medical - Devices
More sections of QTRX: Overview · Financials · Valuation · Statistics · Estimates · Technical · News · Events
Discover more: Radar — undervalued stock signals · Investment Academy — learn to analyze stocks